The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. - Wikidata - wikimedia - TriplyDB

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

http://www.wikidata.org/entity/Q27824784

about

Tumor classification: molecular analysis meets Aristotle Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature Reliability and reproducibility issues in DNA microarray measurements T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6 Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?FABIA: factor analysis for bicluster acquisition Increased cytochrome c correlates with poor survival in aggressive lymphoma Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4 Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score Molecular characterization of centerin, a germinal centre cell serpin 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect Tumor microenvironments, the immune system and cancer survival Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs Semi-supervised methods to predict patient survival from gene expression data BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 stam--a Bioconductor compliant R package for structured analysis of microarray data.A 61-year-old man with dyspepsia and weight loss Gene expression profiling predicts survival in conventional renal cell carcinoma.A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma miR-155 as a Biomarker in B-Cell Malignancies Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis Next-generation prognostic assessment for diffuse large B-cell lymphoma Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis MicroRNAs in B-cells: from normal differentiation to treatment of malignancies Biology of double-hit B-cell lymphomas Thyroid lymphoma: recent advances in diagnosis and optimal management strategies The genetic landscape of diffuse large B-cell lymphoma

P2860

96e284b9d8e0a65f0383d456d856ef557ce7a334 af7527e46743e4e1a8a4238e6e4e47718b385c5d

P248

Q21093319-D09B71CF-F893-4632-A8C6-CE5B07219AD5 Q21146433-29D4D84B-07CE-4E82-AECD-FCD049F40056 Q21198873-3276BAD4-796F-4A18-A254-E7A74A583374 Q24289394-6A65735E-2436-44C4-A11B-FC8C12378F0B Q24338883-8B2AFF23-90DC-4B3D-8A47-4537498CABE2 Q24528253-EB4F97CB-8B21-4E12-AAB7-36CF584761C4 Q24597424-73EB3706-9C28-4D5F-8EC3-58D829E46455 Q24599474-763105C7-F006-4B93-B57E-497427C4C782 Q24627902-3A13C68C-922C-4D70-8730-60FDCEB7C86C Q24630661-BB1C62B9-AFC9-4857-B473-01E02CE3F3F8 Q24633718-457CBEB3-7B42-4027-A8D7-35963BAAD1CD Q24643447-90FACD07-9DBC-4229-ACB3-FD18426372C3 Q24645617-27DF3F7D-D1D4-4351-8BB3-CB011A4367DA Q24646379-83B73A34-909A-4B51-8325-1F4E4D49C987 Q24648046-A4E51E75-41E2-4956-8DE2-B02408A59F75 Q24652565-02AF01FE-1C11-4918-8DE6-DE0EDDF78923 Q24653343-3E526046-DD35-4B77-B8D9-D953A4C3F9C3 Q24654719-CB06C061-31CC-4C5F-8A0B-E35D0138CADC Q24658236-0C61A578-8C4F-431B-95DD-0A3A7965E71E Q24672476-6B3E6359-F213-43C5-B12D-3F811B421710 Q24680233-17FA1039-8E18-47C9-9961-36919EF884AD Q24685660-C274D623-F99F-4DFC-8BD6-69645E041281 Q24796756-6D287D32-17CB-4DC1-A294-100837A34D51 Q24797095-2BC22AF1-54DB-45E7-9456-506E2C9CD52A Q24801085-777F00F1-18FB-4C28-B9AD-07C768D5DE0F Q24804682-4A948B1C-BBB7-488D-8931-618A4B20FA2C Q24806130-799D235C-17B1-4320-85D1-51F451F8BFE3 Q24813023-331C2548-8E01-4BA0-BC8B-099B06AE1E77 Q24813742-2C162EB5-CB6B-4587-9B45-85716EDA3BC4 Q24814730-53A4D559-1226-4C24-AFA1-0315B2F9F356 Q26738937-E297166E-3DBD-4E0C-85FF-C506655BE954 Q26746573-7841E60F-0424-44C9-980B-EA06C9E1DDA2 Q26771059-B737A212-6DD8-42A6-AF4B-978616F6419F Q26795818-CDBE7775-0279-44EC-84BD-AF9D174F4C1D Q26796428-E5D4B198-37EB-4115-BC5B-3F2517D41BC7 Q26822486-27907460-EB91-4070-8DEC-C3A16039A6EB Q26824682-B23AAEC2-80AB-4D28-ACA1-F1E1FDE59496 Q26825581-E7106955-7816-40D4-9792-469160A345C1 Q26827420-F28EDFCE-E9CF-454D-98B3-7B34DED7DBDB Q26866537-E294AFA2-72F9-4F75-A193-867022C5CF92

P2860

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

http://www.wikidata.org/entity/Q27824784

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@ast

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@en

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@nl

type

label

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@ast

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@en

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@nl

prefLabel

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@ast

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@en

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@nl

P1433

Q27824784-7C890DA6-D07C-4659-93B0-5C65E04A78DD

P1476

Q27824784-C82EB8F2-03E1-43CC-B7CE-4B59B521B051

P2093

Q27824784-087B25CA-B21C-4CEF-87E3-EB135161558E

Q27824784-1E5290C9-8C95-4556-88ED-E9B02D71689A

Q27824784-2F4A4000-ABE9-48CE-A89A-4BEF6DF1FF53

Q27824784-3AB7E6F1-F11C-44D8-9DBB-C87AD91E66C1

Q27824784-3FBE9298-CD91-412D-B62C-459F21234EBE

Q27824784-47BE63B4-D0B5-41BB-8ED5-B28333115FD1

Q27824784-738FC81D-2CC7-48C1-B26E-03112A6054DE

Q27824784-7689CE68-C436-4E82-BEF0-151BA9279B34

Q27824784-7A96A8E3-1A6C-45A1-BA8A-0D6855004487

Q27824784-92CE36D9-7CA2-4549-B140-DA37F6C7729C

P304

Q27824784-D86F4789-23AB-4856-8097-B53F9CA59A87

P31

Q27824784-3246F15F-314F-4105-89EF-C43E069076E5

P3181

Q27824784-B77F029A-71E7-46E6-99D4-254A56FCFBB5

P356

Q27824784-C0D40D67-3C19-45CE-A43F-56CFDBCFFDD7

P407

Q27824784-B8EA12B3-F385-4646-B190-6197C1323D19

P433

Q27824784-F85ACF97-6631-41A7-9723-F7EEA2CC2FC8

P478

Q27824784-363272AC-A23E-448C-92BC-5223661557C9

P50

Q27824784-18A493CC-B259-4CC8-B935-2D81E9E477CD

Q27824784-42D4027B-477F-4910-9072-301854F9F914

Q27824784-64004EA8-702A-4E1B-AC52-177F220B02B9

Q27824784-8A00BC4A-5DA8-4E53-9505-2069DC20D5C5

Q27824784-D6070886-9F05-44A5-BF72-CCD9A2D1E8D4

Q27824784-FD76E656-FC04-4272-89D8-6854C7C82322

P577

Q27824784-E66A3C11-BB08-4AB7-B871-8F254D162D4B

P5875

Q27824784-8DFE6D05-20C2-4CC5-9E22-899566409CDB

P698

Q27824784-0F7B0170-2921-4AAD-9D39-95468490B01C

P921

Q27824784-795B1256-C1DD-46E0-9E81-FABB2CA901E5

P3181

P356

P1433

The New England Journal of Medicine

P1476

The use of molecular profiling ...... diffuse large-B-cell lymphoma.

@en

P2093

Dan L Longo

http://www.w3.org/2001/XMLSchema#string

Elaine M Hurt

http://www.w3.org/2001/XMLSchema#string

Elaine S Jaffe

http://www.w3.org/2001/XMLSchema#string

George Wright

http://www.w3.org/2001/XMLSchema#string

H Konrad Muller-Hermelink

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Jena M Giltnane

http://www.w3.org/2001/XMLSchema#string

John Powell

http://www.w3.org/2001/XMLSchema#string

Lauren Averett

http://www.w3.org/2001/XMLSchema#string

Liming Yang

http://www.w3.org/2001/XMLSchema#string

P304

1937-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

537811

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA012914

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

346

http://www.w3.org/2001/XMLSchema#string

P50

Erlend B. Smeland

Andreas Rosenwald

Joseph M Connors

Randy D Gascoyne

P577

2002-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11300007

http://www.w3.org/2001/XMLSchema#string

P698

12075054

http://www.w3.org/2001/XMLSchema#string

P921